Preclinical data shows combination immunotherapy could stop liver cancer growth
Even as overall cancer incidence and mortality decrease in the United States, the number of people diagnosed with liver cancer is on the rise. …
Even as overall cancer incidence and mortality decrease in the United States, the number of people diagnosed with liver cancer is on the rise. …
A large breakthrough has been made in the genetic understanding of mouth ulcers (or canker sores) which could provide potential for a new drug to prevent or heal the painful lesions. …
Study shows how metabolites can be used to inhibit epigenetic mechanisms and effectively treat a range of diseases, including multiple sclerosis. …
A growing number of cancer patients are being offered a promising new treatment called CAR T cell therapy. In this therapy, a patients’ own T cells are removed …
Scientists at the University of Virginia School of Medicine have discovered a defect in immune cells known as “killer T cells” that explains their inability to destroy cancer tumors. …
New research has demonstrated using cell cultures that salt leads to the formation of Th2 cells that are active in allergic immune reactions. …
A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, …
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself. …
Immune cells in the bowel of people who suffer from celiac disease are permanently replaced by a new subset of cells that promote inflammation, …
Scientists have developed an injectable sponge-like gel that enhances the production T-cells after a bone marrow transplant, increasing the quantity and diversity of these key components of the immune system. …
End of content
End of content